InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Senn Sean. Director active across 1 company, notably Immix Biopharma, Inc.. Cumulatively, 2 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €1k. Activity tracked since 14 July 2022. The latest transaction was disclosed on 14 July 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations